Roles of heparan-sulphate glycosaminoglycans in cancer

This publication has 59 references indexed in Scilit:

• Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development
  Seminars in Cancer Biology, 2002
• Improved Cancer Mortality with Low-Molecular-Weight Heparin Treatment: A Review of the Evidence
  Seminars in Thrombosis and Hemostasis, 2002
• Dynamic Regulation of Tumor Growth and Metastasis by Heparan Sulfate Glycosaminoglycans
  Seminars in Thrombosis and Hemostasis, 2002
• Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias
  Leukemia, 2002
• Heparan Sulfate Proteoglycans as Regulators of Fibroblast Growth Factor-2 Receptor Binding in Breast Carcinomas
  The American Journal of Pathology, 2002
• Order out of complexity – protein structures that interact with heparin
  Current Opinion in Structural Biology, 2001
• A Unique Sequence of the Laminin α3 G Domain Binds to Heparin and Promotes Cell Adhesion through Syndecan-2 and -4
  Published by Elsevier ,2001
• Cell Type-specific Differences in Glycosaminoglycans Modulate the Biological Activity of a Heparin-binding Peptide (RKRLQVQLSIRT) from the G Domain of the Laminin α1 Chain
  Journal of Biological Chemistry, 2001
• Experimental Proof for the Structure of a Thrombin-Inhibiting Heparin Molecule
  Chemistry – A European Journal, 2001
• Heparan Sulfate Undergoes Specific Structural Changes during the Progression from Human Colon Adenoma to Carcinoma in Vitro
  Journal of Biological Chemistry, 1998